INTRODUCTION {#S2}
============

The *Neurofibromatosis 1* (*Nf1*) gene, which is mutated in the human disease of the same name, is required for rest:activity rhythms in *Drosophila*. Loss of neurofibromin, the protein product of *Nf1*, renders flies largely arrhythmic, indicating that it serves an important function in the circadian system. Subsequent studies also reported sleep abnormalities in humans with *Nf1* ([@R22]; [@R28]; [@R29]; [@R31]), but these have not been traced to the circadian system, nor have circadian phenotypes been reported in *Nf1* mutant mice despite evidence for altered duration of locomotor activity ([@R44]). Mouse *Nf1* mutants are only available as heterozygotes, because complete loss of *Nf1* is lethal in mice; thus, behavioral analysis of the genetic null has not been possible.

Despite their abrogated behavioral rhythms, *Drosophila* homozygous *Nf1* mutants show normal cycling of key circadian clock proteins, period (PER) and timeless (TIM), in central clock cells, indicating that output from the clock is affected ([@R45]). Consistent with the known function of mammalian neurofibromin as a Ras-GTPase-activating protein (Ras-GAP), effects of *Drosophila Nf1* on rest:activity rhythms are mediated by increased Ras/mitogen-activated protein kinase (MAPK) pathway signaling ([@R45]). However, we still have no understanding of the mechanisms by which *Nf1* affects transmission of time-of-day signals from the clock.

Identification of a circadian output circuit provides a unique opportunity to assess the effects of *Nf1* on cellular function within cells downstream of the clock. In this circuit, the central clock cells, small ventral lateral neurons (sLNvs), signal via a neuropeptide, pigment-dispersing factor (PDF), to a dorsally located clock neuron cluster, DN1, which in turn connects to non-clock cells in the pars intercerebralis (PI) ([@R9]). The PI is the fly equivalent of the hypothalamus and consists of multiple groups of peptidergic neurons, some of which modulate rest:activity rhythms while others regulate metabolic rhythms ([@R5]; [@R9]). The clusters that express the diuretic hormone 44 (DH44) and *Drosophila* neuropeptide AYRKPPFNGSIFamide (SIFamide) peptides, respectively, are important for rest:activity rhythms ([@R9]).

Here, we report that *Nf1* is required broadly within the *Drosophila* circadian circuit for rest:activity rhythms and, consistent with that requirement, affects cellular function in multiple neuronal populations. Specifically, loss of *Nf1* impairs rhythms of intracellular calcium, a correlate of neural activity, as well as peptide expression in subsets of circadian neurons. Reduction of *Nf1* partially rescues rhythms in a PDF receptor mutant, indicating that interactions between neurofibromin and peptide signaling are relevant for behavioral rhythms. As noted earlier, the lethality associated with loss of *Nf1* in mice has thus far impeded assessment of its contribution to circadian regulation. The identification of a cellular endpoint of *Nf1* disruption in flies also allowed us to assay the effect of *Nf1* loss in mammalian cells, specifically mouse astrocytes that are known to be a site of neurofibromin action ([@R39]). We find that calcium levels are rhythmic over a 24-hr day in wild-type astrocytes, but the cycling is dampened in *Nf1*-deficient astrocytes, which exhibit a general elevation in calcium. Altogether, these findings establish a conserved role for neurofibromin in the regulation of daily rhythms.

RESULTS {#S3}
=======

Neurofibromin Is Required Broadly in the Drosophila Brain for Rest:Activity Rhythms {#S4}
-----------------------------------------------------------------------------------

We first sought to identify the anatomical location that mediates effects of *Nf1* on circadian rhythms. Earlier work, using the upstream activating sequence (UAS)-GAL4 system to target *Nf1* expression, indicated that neurofibromin expression in clock neurons was not sufficient for rest:activity rhythms ([@R45]). Other sites, or perhaps even multiple locations, of action were indicated, which is supported by the finding that *Nf1* is expressed broadly across the adult fly brain ([@R8]). Thus, we went beyond the clock cell drivers used in the previous study and assayed for rescue of the mutant phenotype following *Nf1* expression in different neuronal populations of *Nf1* homozygous mutant flies. We found that behavioral rhythms were restored when *Nf1* expression was driven by GAL4 drivers expressed broadly, such as the panneuronal synapto-brevin-GAL4 driver or the Cha-GAL4 driver expressed in all cholinergic cells ([Table 1](#T1){ref-type="table"}). Because most adult fly brain neurons are cholinergic ([@R14]), rescue with the Cha driver does not implicate any specific brain region. In addition, the c309-GAL4 and 53b-GAL4 drivers that are expressed in multiple brain regions yielded partial rescue ([Table 1](#T1){ref-type="table"}).

Consistent with previous findings ([@R45]), neither the *Pdf*-GAL4 driver, expressed specifically in ventral lateral neurons (LNvs), nor the *Clk*4.1-GAL4 driver, which targets DN1s ([@R15]), rescued the *Nf1* mutant phenotype. Rescue was also not seen with expression targeted to mono-aminergic cells using the *ddc*-GAL4 and *Tdc2*-GAL4 drivers. Even the c929-GAL4 driver, which is expressed in most peptidergic cells, including those of the PI ([@R18]), did not rescue the *Nf1* mutant phenotype. These results suggest that neurofibromin is required in more than one location for rest:activity rhythms. However, we acknowledge that negative results with some drivers may be due to the reduced strength of these drivers.

Because the rescuing drivers (e.g., synaptobrevin and Cha-GAL4) are expressed at developmental stages, in addition to the adult stage, we asked whether *Nf1* is required in adults for normal rest:activity rhythms. We drove expression of *Nf1* RNAi with a panneuronally expressed and RU-486 inducible driver, synaptobrevin GeneSwitch (nsyb-GS), and knocked down expression specifically in adults by feeding flies RU-486. Knockdown in adults also reduced rhythm strength, although not to the extent seen in *Nf1* mutants ([Figure S1](#SD1){ref-type="supplementary-material"}). The weaker phenotype could reflect incomplete knockdown by RNAi or an additional role in development. Nevertheless, these data indicate that *Nf1* functions in adults to maintain circadian behavior.

Neurofibromin Function in Circadian Clock Neurons {#S5}
-------------------------------------------------

Given the rather broad requirement for neurofibromin in the generation of circadian behavioral rhythms, we sought to address its impact in different cells of the circadian circuit important for rest:activity rhythms. We started with the LNvs, which express the PDF neuropeptide. Circadian clock proteins were shown to cycle in LNvs of *Nf1* mutant flies ([@R45]), so we examined effects of neurofibromin loss on rhythmic outputs of these neurons. PDF is the major output of these neurons, and its expression is rhythmic at the terminus of the dorsal projection from the sLNvs ([@R35]). To determine whether this rhythm in PDF expression is intact in *Nf1* mutants, we examined expression at times of low and high expression, circadian time (CT) 1 and 13, respectively, in flies maintained in constant darkness (DD) following entrainment to light:dark cycles. Whereas wild-type flies showed a cyclic pattern ([@R35]), PDF expression did not change between time points at the dorsal terminus in *Nf1* mutants and was constantly low ([Figure 1](#F1){ref-type="fig"}).

Because reduced accumulation of PDF at the axon terminal is thought to indicate increased peptide release ([@R35]), PDF signaling might be increased in *Nf1* mutants. We hypothesized that if *Nf1* mutants have increased PDF release, then this could be counteracted by reducing expression of the PDF receptor (PDFR). To test this idea, we generated double mutants of *Nf1* loss coupled with each of two mutant alleles of the PDF receptor, *pdfr*. Like *Nf1* mutants, mutants of PDF or of its receptor are largely arrhythmic, although the limited rhythmic flies show a short period ([@R20]; [@R27]; [@R33]).

We were unable to rescue rest:activity rhythms of *Nf1* homozygous mutants with hypomorphic alleles of *pdfr*, tested as heterozygotes or homozygotes. This is perhaps not surprising, given that *pdfr* action in circadian behavior maps to specific neurons, largely the clock network ([@R21]), while neurofibromin, as demonstrated earlier, is required broadly. *Nf1* not only is required broadly but also affects multiple circadian cells (described later). However, loss of one copy of *Nf1* rescued the short period of both *pdfr* mutants and partially rescued rhythmicity in one of the two mutant lines ([Table 2](#T2){ref-type="table"}). Thus, neurofibromin and PDF interact genetically in the generation of behavioral rhythms.

Small LNvs project to DN1 clock cells, which are part of the circuit required for rest:activity rhythms. To determine whether neurofibromin affects the clock or clock output in DN1s, we first examined the expression of the PER clock protein at different times of day in constant darkness. In *Nf1* mutants, as in wild-type flies, PER expression was cyclic, peaking at CT1 and nadiring at CT13 ([Figure S2](#SD1){ref-type="supplementary-material"}). In the absence of an established molecular assay for rhythmic output in these cells, we measured calcium using a CaLexA reporter ([@R32]). Calcium levels were rhythmic in a subset of DN1s, even in constant darkness following entrainment to light:dark cycles, and the rhythm was evident in both wild-type flies and *Nf1* mutants ([Figure S2](#SD1){ref-type="supplementary-material"}). In addition, we did not detect changes in overall calcium levels in *Nf1* mutants relative to wild-type controls. We conclude that neurofibromin has limited, if any, effects on DN1s.

Neurofibromin Affects Neural Activity in PI Cells that Secrete DH44 {#S6}
-------------------------------------------------------------------

Although cells in the PI do not contain clocks, they receive input from upstream DN1s and are required for different circadian outputs ([@R5]; [@R9]). DH44-positive neurons in the PI are particularly important for the regulation of rest:activity rhythms ([@R9]). To assess a possible role for neurofibromin in these cells, we initially assayed DH44 expression in *Nf1* mutants. Because DH44 expression does not cycle, we examined a single time point in the presence of light:dark cycles (zeitgeber time 13 \[ZT13\]) and in constant darkness (CT13) and found that overall expression of DH44 was not different between wild-type flies and *Nf1* mutants ([Figure 2A](#F2){ref-type="fig"}) (data not shown). However, this did not preclude an effect of neurofibromin on rhythmic output in these cells, which we then assayed by measuring calcium as a proxy for neural activity. As previously reported with a different calcium sensor ([@R10]), the CaLexA reporter revealed a rhythm of calcium in these cells, showing significantly higher levels at ZT13 than at ZT1 ([Figure 2B](#F2){ref-type="fig"}). No such rhythm was seen for calcium in *Nf1* mutants, suggesting that neurofibromin is required for rhythmic output from DH44 cells.

Because cellular rhythms were normal in DN1 neurons, which are upstream of DH44 cells in the circadian circuit, we surmised that neurofibromin had independent effects in DH44 cells. To determine whether the effect was cell autonomous, we attempted to rescue the phenotype in DH44 cells by expressing *Nf1* specifically in these cells in a mutant background. Calcium cycling was restored in flies expressing *Nf1* in DH44 cells, while controls that contained the *Nf1* mutation, but only with the Gal4 transgene and not UAS-*Nf1*, remained arrhythmic. These data indicate that neurofibromin acts in DH44 cells to affect rhythms of calcium.

Neurofibromin Affects Neural Activity in PI Cells that Secrete SIFamide {#S7}
-----------------------------------------------------------------------

SIFamide (SIFa) is expressed in four PI cells, which are also required for rest:activity rhythms ([@R9]). We found that *Nf1* loss dramatically increased *SIFa* mRNA levels ([Figure 3A](#F3){ref-type="fig"}), albeit with a small decrease in the corresponding protein levels as detected in projections throughout the brain ([Figures 3B and 3C](#F3){ref-type="fig"}). Neither RNA nor protein expression was found to cycle, and we did not detect a rhythm in neural activity via calcium imaging. However, *Nf1* mutants showed robust increases in calcium levels in SIFa-producing cells, which is likely indicative of increased release and may account for reduced accumulation of protein ([Figures 3D and 3E](#F3){ref-type="fig"}) ([@R25]; [@R35]). The strongest influence of neurofibromin loss was observed in SIFa-producing cells. As in the case of DH44 cells, the effects of *Nf1* in SIFa cells are likely cell autonomous and independent of those in other circadian cells.

Given the dramatic effects of the *Nf1* mutation on *SIFa* gene expression and SIFa cell activity, we sought to determine whether SIFa contributes to neurofibromin regulation of behavioral rhythms. Although SIFa cells are implicated in circadian rhythms ([@R9]), a role for the peptide has not been tested. To examine this potential role, we generated a *SIFa* mutant by CRISPR/Cas9 genome editing and tested it for circadian rest:activity rhythms. Three independent mutant lines were obtained, and although we observed a small reduction in rhythm strength, this was not consistent across lines and in mutant-deficiency combinations. These results indicate that SIFa is not a major contributor to rest:activity rhythms ([Table 3](#T3){ref-type="table"}), even though the cells that produce it are important.

SIFa is also implicated in the regulation of sleep ([@R36]), as is *Nf1* ([@R3]). It is unclear whether effects of *Nf1* on sleep are related to its effects on circadian rhythms, but overlapping mechanisms are a distinct possibility given that several circadian neurons have roles in sleep ([@R2]). We found, as predicted from RNAi analysis ([@R36]), that *SIFa* mutants have reduced sleep ([Figure S3](#SD1){ref-type="supplementary-material"}), so we asked whether the *Nf1* mutant sleep phenotype is mediated through effects on SIFa expression. We generated double mutants lacking both SIFa and neurofibromin and tested them in sleep assays. Double mutants showed sleep reduction equivalent to that in *Nf1* single mutants ([Figure S3B](#SD1){ref-type="supplementary-material"}), indicating that these two genes act in the same pathway to regulate sleep ([Figure S3](#SD1){ref-type="supplementary-material"}).

Neurofibromin Is Required for Calcium Cycling in Mouse Astrocytes {#S8}
-----------------------------------------------------------------

Neurofibromin has not yet been implicated in circadian rhythms in mammals, although it is associated with sleep phenotypes in humans ([@R22]; [@R28]; [@R29]; [@R31]) and with locomotor activity levels in mice ([@R44]). Detection of rhythm phenotypes in knockout mice is complicated by the complete *Nf1* loss being embryonic lethal (these mice also frequently show exencephaly) ([@R26]), and effects of the mutation may be recessive at the cellular level. Based on the preceding studies that indicated a cellular phenotype in *Nf1* mutant flies, we sought to determine whether a similar abnormal phenotype was manifest in mammalian cells lacking neurofibromin expression. Because we were interested in adult cells and wanted to avoid the lethality associated with neuronal loss, we used mouse brainstem astrocytes in which neurofibromin expression was acutely deleted by Cre-mediated excision ([@R39]). Astrocytes were shown to have an important role in circadian timekeeping in the mammalian central clock, the suprachiasmatic nucleus (SCN), so they are a relevant cell type for this purpose ([@R6]; [@R7]; [@R41]).

Circadian rhythms can be studied in cultured cells by synchronizing clocks across cells with a stimulus like dexamethasone, which is a synthetic glucocorticoid ([@R4]); dexamethasone was even used to assay circadian cycling in astrocytes ([@R6]). Typically, rhythms of gene expression are assayed in such populations, but we were interested in this case in the levels of calcium over a 24-hr day. Astrocytes were treated with dexamethasone to synchronize circadian cycling, and calcium levels were assayed at different times of day with Cal-520, a recently developed fluorogenic calcium-sensitive dye ([@R30]) ([Figure S4A](#SD1){ref-type="supplementary-material"}). Whereas wild-type astrocytes displayed robust 24-hr oscillations of calcium ([Figures 4A and 4B](#F4){ref-type="fig"}; [Figure S3B](#SD1){ref-type="supplementary-material"}), this cycling was dampened and the overall levels of calcium were higher in *Nf1*-deficient astrocytes ([Figures 4C and 4D](#F4){ref-type="fig"}; [Figure S4D](#SD1){ref-type="supplementary-material"}). Altogether, these studies establish a conserved role for neurofibromin in regulating cellular activity rhythms within the nervous system.

DISCUSSION {#S9}
==========

Although the effects of neurofibromin on *Drosophila* circadian rhythms were reported more than 15 years ago, the cellular basis of action has remained elusive ([@R45]). Analysis of other circadian output molecules has also been difficult due to lack of a conceptual framework for output circuitry. Therefore, the identification of neurons downstream of the central clock ([@R9]) allows us to examine the function of output molecules in a cellular context. Leveraging these insights, we show that neurofibromin loss affects neural activity, as well as gene expression, in peptidergic neurons of a circadian circuit required for rest:activity rhythms. The demonstration that neurofibromin is similarly required for calcium-cellular activity rhythms in mouse astrocytes provides evidence for a conserved function of neurofibromin in the generation of rhythms.

Our findings suggest that neurofibromin acts broadly in the *Drosophila* circadian system. Multiple circadian neurons show cellular phenotypes in the *Nf1* mutant background, and only drivers with widespread expression rescue the mutant behavioral phenotype. In previous work, we found that clock function was normal in PDF cells, and neurofibromin expression in these cells was insufficient to drive rhythms ([@R45]; supported also by our current data). As a result, we did not examine the cycling of PDF at the dorsal termini of sLNvs. We now report that this cycling is altered, suggesting that *Nf1* affects outputs of the clock within PDF cells. The behavioral relevance of rhythmic PDF accumulation has been questioned ([@R24]), but subsequent studies have supported a role for cellular rhythms at LNv termini ([@R13]; [@R17]). Loss of *Nf1* abrogates these cellular rhythms, in conjunction with loss of PDF cycling.

PDF expression at sLNv termini is also reduced, which is typically indicative of increased release ([@R25]; [@R35]) and consistent with increased MAPK activity in this region of the brain in *Nf1* mutants ([@R45]). Effects of *Nf1* mutants on rhythms are mediated through increased MAPK activity ([@R45]), which is also a major target of neurofibromin in mammals ([@R38]). Conversely, *Pdf* mutants show decreased MAPK activity. In addition to affecting rhythmic outputs of the sLNvs, neurofibromin is implicated in signaling through the PDFR ([@R33]). The impact of neurofibromin on PDF signaling is relevant to behavioral rhythms, because rhythm phenotypes of *pdfr* are partially rescued by a reduction in *Nf1* gene expression. We infer that increased PDF signaling caused by loss of one copy of *Nf1* compensates for reduced *pdfr* expression (*pdfr* mutants do not appear to be nulls) ([@R20]; [@R27]; [@R33]). *Nf1* mutants are not rescued by a reduction in *pdfr*, most likely because *Nf1* action at multiple sites contributes to the behavioral phenotype. Alternatively, lack of rescue may primarily reflect a need for neurofibromin action downstream of *pdfr*.

Clock function and neural activity are normal in DN1s of *Nf1* mutant flies. Although we cannot exclude other effects in DN1s---for instance, the increased MAPK activity mentioned earlier may occur in DN1s---it is unlikely that effects in DN1s account for the strong effect of *Nf1* on downstream PI cells. More likely, the PI phenotypes in *Nf1* mutant flies represent additional sites of neurofibromin action and are not secondary to upstream defects in the pathway. This interpretation is supported by cell-autonomous rescue of the phenotype in DH44 cells. It is also consistent with the broad requirement for neurofibromin in the rescue of behavioral rhythms and the lack of rescue of the *Nf1* behavioral phenotype by *pdfr* mutants.

Dampened cycling of neural activity in DH44 cells of the PI is likely an important contributor to the arrhythmic phenotype, because these cells are critical for circadian behavioral rhythms ([@R9]; [@R23]). The phase of calcium we report here is the same as that reported previously ([@R10]) and consistent with a role for DH44 in the evening peak of locomotor activity ([@R23]). An even stronger phenotype is observed in *Nf1* mutants in cells that produce SIFa. These cells show very high activity and higher levels of SIFa mRNA, although the levels of protein are not elevated. We suggest that the protein does not accumulate because it is constantly secreted in response to the high neural activity; mRNA levels may increase to compensate for the continually depleted protein. *Nf1* phenotypes in circadian cells indicate not only a cellular mechanism of action but also potential molecular targets (PDF and SIFa). Genetic interactions of *Nf1* with *pdfr* in the context of circadian rhythms and with *SIFa* in the regulation of sleep suggest that these molecular targets are relevant for behavior. We suggest that effects of neurofibromin loss on sleep result from dysregulated SIFa signaling. Effects of *Drosophila Nf1* on peptidergic signaling are supported by a former report showing rescue of synaptic growth phenotypes in *Nf1* flies by a mutation in a peptide receptor ([@R42]).

To extend our findings of aberrant calcium signals and neural activity in *Nf1* mutant flies to higher organisms, we sought to determine whether these phenotypes were conserved in mammals. Herein, we show that astrocytes display rhythmic calcium cycling, likely reflecting rhythmic cellular activity, and that these rhythms are attenuated in *Nf1^−/−^* cells. Increased excitability and secretion phenotypes were found in *Nf1*-deficient mouse cells ([@R19]; [@R43]), and although the mechanisms are still unclear, they may involve post-translational modification of N-type calcium channels ([@R12]). Given that neurofibromin is a potent regulator of MAPK activity, phosphorylation is a candidate mechanism for such modifications. However, effects of *Nf1* on cellular activity or excitability have not been studied in the context of rhythms. In addition, as indicated earlier, assays of behavioral rhythms in *Nf1* mutant mice have been complicated by the lethality of the null mutant.

The extent of neurofibromin loss in *Nf1* patients tends to vary considerably. Homozygous *Nf1* loss in human brain neurons has not yet been reported, but studies have demonstrated that not all germline *NF1* gene mutations are equivalent, with some leading to dramatic reductions in neurofibromin expression (\>80%) and others exhibiting more modest effects ([@R1]). Recapitulating these mutational differences in mice produces variations in the penetrance and severity of phenotypes ([@R40]), which is likely also the case in humans. It is possible that circadian rhythm abnormalities would only be observed in individuals with strong hypomorphic germline mutations in the *Nf1* gene. Nevertheless, deficits in sleep initiation and maintenance have been reported in children with neurofibromatosis ([@R22]; [@R28]; [@R29]; [@R31]) and could have their basis in the mechanisms we report here.

EXPERIMENTAL PROCEDURES {#S10}
=======================

Fly Lines {#S11}
---------

The GAL4 lines were used previously in the lab ([@R3]; [@R9]; [@R11]). *Nf1^P1^*, *Nf1^P2^*, and UAS-*Nf1* lines were reported ([@R45]) and were outcrossed into an *iso31* background for 7 generations. Bloomington line Df27352 was used as an *SIFa* deficiency allele (2R:60C2;60D14) tested in transheterozygotes with *SIFa* CRISPR alleles. CaLexA flies were a gift from J. Wang. UAS-RedStinger flies were obtained from the Bloomington Drosophila Stock Center.

Generation of *Nsyb-GS* Flies {#S12}
-----------------------------

*nsyb-GS* construct was generated using Gateway cloning (Invitrogen) and the construct was targeted to the PhiC31-attP2 landing site on the third chromosome (3L:68A4) in *Drosophila*. A 1,917 bp fragment of the *Drosophila n-synap-tobrevin* (Nsyb) promoter (matching the fragment used to generate *Nsyb-GAL4* flies by Julie Simpson, Janelia Farm Research Campus) was PCR amplified from *Canton-S* flies and recombined into the Gateway pDonr221 vector using primers containing Gateway attB1/2 sites: attB1_Nsyb1917_5′, 5′-GGGGACAAGTTTGTACAAAAAAGCAGGCTgaattcgacctcaaagatggaagc-3′, and attB2_Nsyb1917_3′, 5′-GGGGACCACTTTGTACAAGAAAGCTGGGTAgaattcggctgtc gatgattagg-3′. The *Geneswitch* transgene was PCR amplified from *Elav-GS* flies ([@R34]) and recombined into the Gateway pDonrP2rP3 vector using primers containing a 5′ Kozac sequence and Gateway attB2r/3 sites: attB2r_GS_5′, 5′-GGGGACAGCTTTCTTGTACAAAGTGGAAcaacatgga ctcccagcagccaga-3′, and attB3_GS_3′, 5′-GGGGACAACTTTGTATAATAAAG TTGCttaggagctgatctgactcagcaggg-3′. Entry vector insertions were verified by sequencing. The *Nsyb* promoter sequence was largely similar, but not identical, to sequences in FlyBase (4 mismatches). *Nsyb*-promoter and *Genes-witch* entry vectors were recombined into the *Drosophila* pBPGUw-R1R3-p10 vector ([@R16]) and injected into flies. To verify induction of UAS expression with RU-486, *Nsyb-GS* flies were crossed to *UAS-mCD8-GFP* and brain-GFP expression was compared in flies fed with or without 500 μM RU-486 (Mifepristone, Sigma) in the food. Although a low level of GFP expression was apparent in flies without RU-486, indicating some leakiness, GFP intensity was dramatically brighter in flies fed RU-486.

Generation of *SIFa* Mutants {#S13}
----------------------------

The *SIFa* mutants were generated with CRISPR/Cas9-mediated genome editing ([@R37]). Tandem *SIFa*-targeting guide RNA sequences flanking the *SIFa* coding region were introduced into pCFD4 (Addgene plasmid 49411) using the primers *SIFa*-KO-Forward (5′-TATATAGGAA AGATATCCGGGTGAACTTCGTAggctcgagatcagttctGTTTTAGAGCTAGAAAT AGCAAG-3′) and SIFa-KO-Reverse (5′-ATTTTAACTTGCTATTTCTAGCT CTAAAACcaacgctcaccgaaaactgcGACGTTAAATTGAAAATAGGTC-3′) (*SIFa*-specific sequences are in lowercase) and following the protocol as described in <http://www.crisprflydesign.org/wp-content/uploads/2014/06/Cloning-with-pCFD4.pdf>. The targeting plasmid was injected into fly embryos (Bloomington Drosophila Stock Center \[BDSC\] 51323) using BestGene Transgenic services. We screened for deletions in the *SIFa* gene region with PCR sequencing using the primers *SIFa*\_del_F1 (5′-aagcaggagagcgagttcag-3′) and *SIFa*\_del_R1 (5′-ttcgccttgttttgtcacag-3′). Three *SIFa* deletion lines with minor differences in the *SIFa* genomic region were characterized (*SIFa^1^* deletion 2R:24577800-24578100, *SIFa^2^* deletion 2R:24577763-24578080, and *SIFa^3^* deletion 2R:24577787-24578087). All three deletions cover both exons of *SIFa*. The mutant lines were backcrossed to iso31 flies 7 times before testing.

Immunohistochemistry {#S14}
--------------------

Adult fly brains were dissected in cold PBS with 0.1% Triton-X (PBST) and fixed in 4% formaldehyde for 15--20 min on ice. Brains were rinsed 3 × 10 min with PBST, blocked for 30--60 min in 5% normal donkey serum in PBST (NDST), and incubated overnight (ON) at 4°C in primary antibody diluted in NDST. Brains were then rinsed 4 × 10 min in PBST, incubated 2 hr in secondary antibody diluted in NDST, rinsed 4 × 10 min in PBST, and mounted with Vectashield. The following primary antibodies were used: rabbit anti-GFP 1:1,000 (Molecular Probes A-11122), rabbit anti-DH44 1:500 ([@R22]), guinea pig anti-PER 1:1,000 (I. Edery), mouse anti-PDF 1:500 (Developmental Studies Hybridoma Bank PDFC7; generated by J. Blau), and rabbit anti-SIFa 1:4,000 (gift from J. Veenstra). Secondary antibodies were as follows: Alexa Fluor 488 goat anti-rabbit 1:500 (Molecular Probes A-11008), fluorescein isothiocyanate (FITC) anti-guinea pig 1:500 (Jackson Laboratory 106-095-003), Cy5 donkey anti-mouse 1:400 (Jackson Laboratory 715-175-151), and Alexa Fluor 633 goat anti-rabbit (Molecular Probes A-21070). GFP signal from the CaLexA reporter system was detected with rabbit anti-GFP antibody followed by Alexa Fluor 488 goat anti-rabbit secondary antibody. Immunolabeled brains were visualized with a TCS SP5 confocal microscope.

Image Analysis {#S15}
--------------

All images were analyzed with ImageJ software. For PDF intensity at sLNv dorsal termini, the terminus region was manually selected as a box, including the axon terminus upward from the branching point, and then thresholded with the average background staining level for the boxed region. The integrated intensity was measured and compared between genotypes. For quantification of CaLexA signals, each cytoplasmic area was manually selected and mean intensity was measured. Nuclear RedStinger expression is calcium independent and was used to normalize the GFP signals, except in [Figure 2C](#F2){ref-type="fig"}, where the GFP signals were normalized to the mean background intensity of the brain.

Sleep Assays {#S16}
------------

Sleep was monitored with the single-beam Drosophila Activity Monitoring System (Trikinetics, Waltham, MA) or, when indicated, with multi-beam monitors (Trikinetics, Waltham, MA) as described previously ([@R3]).

Rest:Activity Rhythm Analysis {#S17}
-----------------------------

Locomotor activity assays were performed with the Drosophila Activity Monitoring System (Trikinetics, MA) as described previously ([@R9]). Individual male flies were loaded into glass tubes containing 5% sucrose and 2% agar. Flies were entrained to a 12:12 light:dark (LD) cycle for 3 days and then transferred to constant darkness. Locomotor activity during days 1--7 in constant darkness was analyzed with Clocklab software (Actimetrics, Wilmette, IL). A fly was considered rhythmic if it met 2 criteria: it displayed (1) a rhythm with 95% confidence using χ^2^ periodogram analysis and (2) a corresponding fast Fourier transform (FFT) value above 0.01 for the determined period. Rhythm strength was categorized as weak (0.01--0.03), moderate (0.03--0.05), or strong (≥0.05).

Rhythms in Astrocyte Cultures {#S18}
-----------------------------

Wild-type and *Nf1^−/−^* astrocyte cultures were generated as previously described ([@R39]). Brainstem astrocytes obtained from *Nf1*^flox/flox^ mouse pups (postnatal days 1--2) were infected with adenovirus type 5 containing β-galactosidase (Ad5-LacZ) or Cre recombinase (Ad5-Cre) (University of Iowa Gene Transfer Core, Iowa City, IA) to produce wild-type or *Nf1^−/−^* astrocytes, respectively. Loss of neurofibromin expression was confirmed by western blotting (Santa Cruz sc-67).

Following three passages (including those in which cells were generated and manipulated to delete *Nf1*), wild-type and *Nf1^−/−^* astrocytes were seeded overnight at 50,000 cells per well in 24 wells with collagen-coated coverslips. 24 hr after treatment with 1 μM dexamethasone (Sigma D2915), 4 μM Cal 520 acetoxymethyl ester (AM) (Abcam ab171868) in Hank's balanced salt solution (HBSS; Thermo Fisher Scientific 14175079) buffer with 1 mM probenecid (Abcam ab145725) was added into the wells at the indicated time points, and the cells were incubated at 37°C for 2 hr. The addition of probenecid inhibited organic anion transporters and thereby reduce efflux of the calcium indicator from the cell. The cells were washed three times with HBSS containing 1 mM probenecid and then fixed with 4% paraformaldehyde (PFA). They were imaged with a fluorescence microscope using FITC (excitation \[Ex.\] = 492 nm and emission \[Em.\] = 514 nm) and DAPI (Ex. = 370 nm and Em. = 460 nm) filter sets with the same light exposure time. For statistical analysis, the fluorescence intensity of ten wild-type or mutant cells was measured at each time point using ImageJ analysis software, and the results were plotted as line graphs. For statistical analyses of circadian parameters, the calcium data were subjected to Jonckheere-Terpstra-Kendall (JTK)\_CYCLE and Lomb-Scargle (LS) analysis using the Meta-cycle R program as described ([@R46]).

Statistics {#S19}
----------

Data were analyzed and plotted with the GraphPad Prism software. Details of statistical analysis are provided in the figure legends, along with the p values corresponding to the asterisks in the figures.
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======================
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![PDF Accumulation Is Reduced in the Dorsal Brain in *Nf1* Mutants\
(A) Schematic drawing of the fly brain showing the circadian circuit for locomotor rhythms, which includes the master pacemaker s-LNvs (magenta), DN1 clock cells (green), and DH44+ (cyan) and SIFa+ (yellow) cells in the PI. The dashed box shows the region of the dorsal brain imaged in (B).\
(B) PDF staining in the dorsal termini of s-LNvs at CT1 and CT13 in *iso31* and *Nf1^P1/P2^* mutant flies. CT, circadian time. Representative images are shown in the top panel. Quantification of average staining intensity (mean ± SEM) is shown in the bottom panel. \*\*\*\*p \< 0.0001, \*p \< 0.05 (one-way ANOVA and Tukey's multiple comparison test). n = 14 brains for *iso31* CT1, *iso31* CT13, and *Nf1* CT1, and n = 11 brains for *Nf1* CT13. See [Figure S2](#SD1){ref-type="supplementary-material"} for analysis of DN1 neurons.](nihms957839f1){#F1}

![Neurofibromin Has Cell-Autonomous Effects on Rhythms of Neural Activity in DH44+ PI Neurons\
(A) DH44 expression was not significantly different between *iso31* and *Nf1^P1/P2^* mutants. The bar graph shows mean ± SEM. n = 5 for iso31, and n = 6 for *Nf1*^P1/P2^.\
(B) Normalized fluorescence from calcium-dependent GFP expression in DH44-GAL4 \> CaLexA/RedStinger flies. The complete genotypes are as follows: control: *UAS-RedStinger, lexAop2-mCD8::GFP/DH44-G4; UAS-mLEXA-VP16-NFAT, LexAop-CD2-GFP*/+. *Nf1^P1/P2^*: *UAS-RedStinger, lexAop2-mCD8::GFP/DH44-G4; UAS-mLEXA-VP16-NFAT, LexAop-CD2-GFP, Nf1^P1^/Nf1^P2^*. Although CaLexA GFP signals in DH44 neurons were not significantly different between control and *Nf1^P1/P2^* flies at either the ZT1 or the ZT13 time point, there was a significant difference in fluorescence intensity between ZT1 and ZT13 in control flies (\*\*\*\*p \< 0.0001) that was not observed in *Nf1^P1/P2^* flies (one-way ANOVA and Tukey's multiple comparison test). n = 24--42 cells.\
(C) Expression of transgenic *Nf1* in DH44 cells of *Nf1* mutant flies rescues cycling of calcium. Fluorescence from the CaLexA reporter in DH44 cells was normalized to the mean background intensity of the brain in *Nf1* mutants expressing *Nf1* in DH44 cells (*UAS-RedStinger, lexAop2-mCD8::GFP*/+*; UAS-mLEXA-VP16-NFAT, LexAop-CD2-GFP, Nf1^P1^/DH44-Gal4, UAS-Nf1, Nf1^P1^*) and in controls that lacked UAS-*Nf1* (*UAS-RedStinger, lexAop2-mCD8::GFP/+; UAS-mLEXA-VP16-NFAT, LexAop-CD2-GFP, Nf1^P1^/DH44-Gal4, Nf1^P1^*). JTK_CYCLE indicated a rhythm in rescued flies. n = 15--26 cells from 4--7 brains per time point.](nihms957839f2){#F2}

![Expression of SIFa and Calcium Oscillations of SIFa+ PI Neurons Are Altered in *Nf1^P1/P2^* Mutant Flies\
(A) *SIFa* mRNA levels throughout the day, normalized to α-tublin, in *Nf1^P1/P2^* mutants (red) and control iso31 (black) flies. Comparisons were with two-way ANOVA and Tukey post hoc test. \*\*p \< 0.01, \*\*\*p \< 0.001. n = 5 independent experiments. Error bars represent SEM.\
(B) SIFa staining intensity averaged over the whole brain in *Nf1^P1/P2^* mutants (red) and control *iso31* (black) flies. Comparisons were with two-way ANOVA and Tukey post hoc test. \*\*p \< 0.01, n.s., not significant. n = 36--48 cells each. Error bars represent SEM.\
(C) Representative images of SIFa brain staining. The white dashed lines outline the brains.\
(D) Normalized fluorescence from expression of the CaLexA reporter in SIFa neurons. The complete genotypes are as follows: control (black): *UAS-RedStinger, lexAop2-mCD8::GFP/ SIFa-G4; UAS-mLEXA-VP16-NFAT*/+. *Nf1^P1/P2^* (red): *UAS-RedStinger, lexAop2-mCD8::GFP/ SIFa-G4; UAS-mLEXA-VP16-NFAT, Nf1^P1^/Nf1^P2^*. Two-way ANOVA and Tukey's test. \*\*\*p \< 0.001, \*\*\*\*p \< 0.0001; n.s., not significant. n = 24--44 cells each. Error bars represent SEM.\
(E) Representative images of the CaLexA GFP signal in SIFa neurons.\
See also [Figure S3](#SD1){ref-type="supplementary-material"}.](nihms957839f3){#F3}

![Genetic Ablation of *Nf1* Upregulates Calcium Levels and Disrupts Calcium Oscillations in Mammalian Astrocytes\
(A) Fluorescence images of a time course of changes in calcium in wild-type (control) and *Nf1^−/−^* (MUT) astrocytes after dexamethasone stimulation. Images were taken at low magnification (40×) using a FITC filter set (474 nm excitation and 530 nm emission). Scale bar, 50 μm. See [Figures S4A and S4B](#SD1){ref-type="supplementary-material"} for detailed experimental procedures and higher-magnification images.\
(B and C) Quantitative measurement of calcium changes in ten wild-type (control) astrocytes (B) or *Nf1^−/−^* (MUT) astrocytes (C) at the time points indicated. The results are plotted as line graphs. See [Figure S4C](#SD1){ref-type="supplementary-material"} for details of quantitative calcium measurements in single cells.\
(D) Quantitative comparison of changes of calcium levels over time in wild-type (control) and mutant (MUT) astrocytes. Error bars represent SD of the mean. \*\*p \< 0.05, \*\*\*p \< 0.0005.\
[Figure S4D](#SD1){ref-type="supplementary-material"} provides statistical analysis of time-of-day effects, using JTK_CYCLE and Lomb-Scargle algorithms.](nihms957839f4){#F4}

###### 

Rescue of Rhythms in *Nf1* Mutants by Restoring NF1 in Subsets of Neurons

  Genotype                                       R (%) (n)      Period ± SEM (hr)   FFT ± SEM
  ---------------------------------------------- -------------- ------------------- ---------------
  *n-syb*-Gal4/+;*UAS-Nf1*,*Nf1^P1^*/*Nf1^P2^*   100 (18/18)    23.78 ± 0.16        0.050 ± 0.006
  *n-syb*-Gal4/+;*Nf1^P1/P2^*                    0 (0/22)                           
  *Cha*-Gal4/+;*UAS-Nf1*,*Nf1^P1^*/*Nf1^P2^*     100 (20/20)    23.77 ± 0.10        0.067 ± 0.008
  *Cha*-Gal4/+;*Nf1^P1/P2^*                      4.3 (1/23)     23.75               0.03
  *Ddc*-Gal4/+;*UAS-Nf1*,*Nf1^P1^*/*Nf1^P2^*     7.7 (1/13)     23                  0.02
  *Ddc*-Gal4/+;*Nf1^P1/P2^*                      0 (0/13)                           
  *Tdc*-Gal4/+;*UAS-Nf1*,*Nf1^P1^*/*Nf1^P2^*     2.8 (3/36)     23.67 ± 0.21        0.023 ± 0.003
  *Tdc*-Gal4/+;*Nf1^P1/p2^*                      0 (0/10)                           
  C453/+;*UAS-Nf1*,*Nf1^P1^*/*Nf1^P2^*           19.0 (4/21)    24.12 ± 0.27        0.025 ± 0.006
  C453/+;*Nf1^P1/P2^*                            0 (0/13)                           
  1471/+;*UAS-Nf1*,*Nf1^P1^*/*Nf1^P2^*           11.1 (2/18)    24.58 ± 2.08        0.03 ± 0.01
  1471/+;*Nf1^P1/P2^*                            0 (0/13)                           
  201y/+;*UAS-Nf1*,*Nf1^P1^*/*Nf1^P2^*           0 (0/32)                           
  201y/+;*Nf1^P1/P2^*                            0 (0/7)                            
  C309/+;*UAS-Nf1*,*Nf1^P1^*/*Nf1^P2^*           50 (13/26)     24.10 ± 0.43        0.055 ± 0.006
  C309/+;*Nf1^P1/P2^*                            0 (0/10)                           
  112749/+;*UAS-Nf1*,*Nf1^P1^*/*Nf1^P2^*         15.6 (5/32)    24.10 ± 0.36        0.014 ± 0.002
  112749/+;*Nf1^P1/P2^*                          0 (0/16)                           
  53b/+;*UAS-Nf1*,*Nf1^P1^*/*Nf1^P2^*            57.1 (16/28)   24.06 ± 0.21        0.024 ± 0.005
  53b/+;*Nf1^P1/P2^*                             0 (0/13)                           
  C739/+;*UAS-Nf1*,*Nf1^P1^*/*Nf1^P2^*           0 (0/16)                           
  C739/+;*Nf1^P1/P2^*                            0 (0/3)                            
  C929/+;*UAS-Nf1*,*Nf1^P1^*/*Nf1^P2^*           0 (0/17)                           
  C929/+;*Nf1^P1/P2^*                            0 (0/11)                           
  MJ63/+;*UAS-Nf1*,*Nf1^P1^*/*Nf1^P2^*           23.1 (3/13)    23.83 ± 0.25        0.017 ± 0.007
  MJ63/+;*Nf1^P1/P2^*                            0 (0/14)                           
  Kurs58/+;*UAS-Nf1*,*Nf1^P1^*/*Nf1^P2^*         25.0 (4/16)    22.96 ± 0.10        0.015 ± 0.04
  Kurs58/+;*Nf1^P1/P2^*                          8.7 (2/23)     23.74 ± 0.23        0.030 ± 0.07
  *Clk*4.1 m/+;*UAS-Nf1*,*Nf1^P1^*/*Nf1^P2^*     8.0 (2/25)     23.57 ± 0.20        0.032 ± 0.004
  *Clk*4.1 m/+;*Nf1^P1/P2^*                      4.5 (1/22)     23.92               0.029
  InSITE911/+;*UAS-Nf1*,*Nf1^P1^*/*Nf1^P2^*      0 (0/6)                            
  InSITE911/+;*Nf1^P1/P2^*                       0 (0/11)                           
  121y/+;*UAS-Nf1*,*Nf1^P1^*/*Nf1^P2^*           8.3 (1/12)     23.83               0.036
  121y/+;*Nf1^P1/P2^*                            0 (0/4)                            
  *Pdf*-G4/+;*UAS-Nf1*,*Nf1^P1^*/*Nf1^P2^*       7.6 (1/13)     23.33               0.011
  *Pdf*-G4/+;*Nf1^P1/P2^*                        0 (0/13)                           
  *UAS-Nf1*,*Nf1^P1^*/*Nf1^P2^*                  8.9 (2/23)     23.46 ± 0.13        0.002 ± 0.000

See [Figure S1](#SD1){ref-type="supplementary-material"} for adult-specific effects of *Nf1* knockdown. Flies showing a fast Fourier transform (FFT) value \>0.01 are counted as rhythmic (R). The average periods and FFTs shown represent the means ± SEM for all rhythmic flies. FFT values were calculated for the first 7 days in constant darkness.

###### 

*Nf1^P1^* Rescues the Short Period Phenotype of the *pdfr* Mutant

  Genotype                      N    SR (%)   MR (%)   WR (%)   AR (%)   FFT ± SEM                                             Period ± SEM (hr)
  ----------------------------- ---- -------- -------- -------- -------- ----------------------------------------------------- ----------------------------------------------------
  iso31                         64   87.5     9.4      1.6      1.6      0.089 ± 0.004                                         23.79 ± 0.10
  *Nf1^P1^*/+                   62   48.4     33.9     9.7      8.1      0.065 ± 0.004[\*](#TFN4){ref-type="table-fn"}         23.72 ± 0.08
  *pdfr^33068^*/Y               32   3.1      9.4      43.8     43.8     0.026 ± 0.012[\*\*\*\*](#TFN3){ref-type="table-fn"}   22.63 ± 0.15[\*\*\*\*](#TFN3){ref-type="table-fn"}
  *pdfr^33069^*/Y               31   3.2      9.7      32.3     54.8     0.025 ± 0.013[\*\*\*\*](#TFN3){ref-type="table-fn"}   22.83 ± 0.22[\*\*\*\*](#TFN3){ref-type="table-fn"}
  *pdfr^33068^*/Y;*Nf1^P1^*/+   32   0.0      15.6     43.8     40.6     0.022 ± 0.010[\*\*\*\*](#TFN3){ref-type="table-fn"}   23.57 ± 0.06 NS
  *pdfr^33069^*/Y;*Nf1^P1^*/+   30   16.7     16.7     46.7     20.0     0.047 ± 0.009[\*\*\*\*](#TFN3){ref-type="table-fn"}   23.58 ± 0.06 NS

SR, strongly rhythmic; MR, moderately rhythmic; WR, weakly arrhythmic; AR, arrhythmic.

p \< 0.0001,

p \< 0.05; NS, not significant, compared with *iso31*. In addition to period, loss of one copy of *Nf1* partially rescues overall rhythmicity and rhythm strength of the *Pdfr^33069^* allele.

###### 

*SIFa* Mutants Are Rhythmic

  Genotype      N    SR (%)   MR (%)   WR (%)   AR (%)   FFT ± SEM       Period ± SEM (hr)
  ------------- ---- -------- -------- -------- -------- --------------- -------------------
  iso31         16   87.5     6.3      0.0      0.0      0.133 ± 0.016   23.83 ± 0.03
  SIFa^1^/+     11   100.0    0.0      0.0      0.0      0.140 ± 0.014   23.85 ± 0.05
  SIFa^1^       15   26.7     33.3     26.7     0.0      0.055 ± 0.011   24.04 ± 0.09
  SIFa^1^/Def   16   56.3     18.8     25.0     6.7      0.059 ± 0.011   24.59 ± 0.17
  SIFa^2^/+     8    100.0    0.0      0.0      0.0      0.149 ± 0.014   23.84 ± 0.08
  SIFa^2^       15   86.7     0.0      13.3     0.0      0.100 ± 0.013   23.89 ± 0.07
  SIFa^2^/Def   16   56.3     0.0      31.3     0.0      0.039 ± 0.005   24.14 ± 0.13
  SIFa^3^/+     5    100.0    0.0      0.0      0.0      0.120 ± 0.006   23.83 ± 0.03
  SIFa^3^       16   68.8     12.5     6.3      12.5     0.092 ± 0.013   23.94 ± 0.04
  SIFa^3^/Def   16   43.8     6.3      50.0     0.0      0.059 ± 0.010   24.86 ± 0.12

SR, strongly rhythmic; MR, moderately rhythmic; WR, weakly arrhythmic; AR, arrhythmic.

###### Highlights

-   Loss of *Nf1* affects calcium levels in a circadian circuit in *Drosophila*

-   *Nf1* interacts with peptidergic signaling to influence behavior

-   Mammalian astrocytes lacking *Nf1* show dampened cycling of calcium

[^1]: Lead Contact
